IVT PCV-25

Pneumococcal conjugate vaccine, 25-valent · Inventprise Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IVT PCV-25, covering 2025-09-02 to 2025-09-02. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants [Phase 2]

See pricing